Trending...
- DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against JOYY, Inc. and Encourages Investors to Contact the Firm
- New Rochelle: Commercial Burglary- Three Suspects Sought
- Thirteen MBK Senior Living Communities Receive "2021 Best of Senior Living" Distinction
The global in-vitro diagnostic market size is predicted to progress at a CAGR of 6.6% in coming years by P&S Intelligence.
NEW YORK - Nyenta -- The global in-vitro diagnostic market reached a valuation of $63.5 billion in 2019 and is predicted to progress at a CAGR of 6.6% between 2020 and 2030. According to the estimates of P&S Intelligence, a market research firm based in India, the market would generate a revenue of $127.4 billion by 2030. The key factor driving the progress of the market is the rising enactment of strict regulations and policies in several countries regarding blood sample contamination.
Besides the aforementioned factor, the growing incidence of chronic diseases, the surging number of blood donors, rapid advancements and innovations in the IVD technology, the increasing number of academic institutions and hospitals, and soaring healthcare expenditure in various countries are also fueling the expansion of the in-vitro diagnostic market across the world. As per the International Diabetes Federation (IDF) Atlas 9th edition, 352 million people in the age group 20—64 were diagnosed with diabetes in 2019.
More on Nyenta.com
Geographically, the in vitro diagnostic market (https://www.psmarketresearch.com/market-analysis/in-vitro-diagnostic-market) is predicted to exhibit the fastest growth in the Asia-Pacific region in the upcoming years. This would be because of the existence of leading market players in the region and their focus on various strategic development activities in order to improve their market position. For example, according to Abbott Laboratories, in October 2019, the Australian Red Cross Blood Service signed a multi-year agreement for Alinity system, the organization's plasma and blood screening technology.
Hence, it can be said without any hesitation that the market would boom in the future years, primarily because of the increasing requirement for blood donations and the growing enactment of several strict policies regarding blood contamination in several countries around the world.
Besides the aforementioned factor, the growing incidence of chronic diseases, the surging number of blood donors, rapid advancements and innovations in the IVD technology, the increasing number of academic institutions and hospitals, and soaring healthcare expenditure in various countries are also fueling the expansion of the in-vitro diagnostic market across the world. As per the International Diabetes Federation (IDF) Atlas 9th edition, 352 million people in the age group 20—64 were diagnosed with diabetes in 2019.
More on Nyenta.com
- Edgemont Partners Advises Prescient Healthcare Group on Its investment by Bridgepoint
- SHAREHOLDER DEADLINE ALERT: WeissLaw LLP Reminds SolarWinds Corporation Shareholders About Its Ongoing Investigation
- Rustic Deco Launches B2B Wholesale Furniture Website
- New Rochelle: Applications Now Available for First Annual Little Hoopers Basketball Clinic
- Ponos Industries Extends Tender Offer for up to 2,000,000 Shares of Common Stock of Verizon Communications Inc
Geographically, the in vitro diagnostic market (https://www.psmarketresearch.com/market-analysis/in-vitro-diagnostic-market) is predicted to exhibit the fastest growth in the Asia-Pacific region in the upcoming years. This would be because of the existence of leading market players in the region and their focus on various strategic development activities in order to improve their market position. For example, according to Abbott Laboratories, in October 2019, the Australian Red Cross Blood Service signed a multi-year agreement for Alinity system, the organization's plasma and blood screening technology.
Hence, it can be said without any hesitation that the market would boom in the future years, primarily because of the increasing requirement for blood donations and the growing enactment of several strict policies regarding blood contamination in several countries around the world.
Source: P&S Intelligence
Filed Under: Health
0 Comments
Latest on Nyenta.com
- IOTech names Gavin Hunter as VP of global marketing
- One of the Last Remaining Sports Apparel Companies with Direct Lineage to the Negro Leagues Creates a Limited Edition Capsule to Celebrate the Centennial of The National Negro Leagues
- Introducing BIAMI.IO Apps Framework
- Tapestry, Inc. to Host FY21 Second Quarter Earnings Call
- K2 Sports Upgrades B2B eCommerce With Emerald's Elastic Suite Platform
- Announcement of Results of Tender Offer for Any and All 2024 Notes by Simpar Europe
- Rochester: Statement Regarding the Inauguration of President Biden and Vice President Harris
- EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against 9F Inc. – JFU
- Bonnie Fuller Assumes Full Ownership of Hollywood Life
- Mayor Mike Spano, Yonkers Public Schools Launch Rev. Dr. Martin Luther King, Jr. Video Contest
- Famer, Alliance Fastpitch Announce Multi-Year Partnership to Deliver Softball Training Curriculum
- Tracker Capital Acquires Presage Security
- Authentic Equity Acquisition Corp. Announces Closing of $230 Million Initial Public Offering of Securities Including Full Exercise of Overallotment Option
- Waste Management & NYC Department of Sanitation Presenting 4th Annual M/WBE Forum
- City Streaming TV, a Streaming Television Inc Network Launches, bringing Community and Faith Leaders into local TV's, At No Cost
- MetroPlusHealth Announces President and Chief Executive Officer Talya Schwartz, MD, Honored Again by City & State as One of New York City's 2021 "Health Power 100"
- Too Lost Gives Independent Musicians a New Option for Distributing and Marketing Their Music
- FEATURED RELEASE: "Everything" by S.P.O.T
- BoatDealers.ca Surges with Record Traffic in 2020
- Working is on at IBEX Packaging with all SOPs during Covid-19